Technology area: Medical Devices & Mechanical Engineering
3 pending office actions • 1 art units • 2 examiners • 0 of 3 (0%) have an AI response strategy ready
Bioprotect Ltd. has 3 pending office actions in the Medical Devices & Mechanical Engineering technology area. These actions are handled by 2 distinct examiners. All 3 pending actions are located within 1 distinct art unit, indicating a very narrow technical focus for the current portfolio. DANG, ANH TIEU is the busiest examiner, managing 2 of the pending office actions. This means a single examiner is responsible for two-thirds of the company's 3 pending matters.
The centralization within 1 distinct art unit and the involvement of only 2 distinct examiners suggests a highly concentrated prosecution environment. This concentration allows for a more consistent strategy across the 3 pending office actions, as they are all reviewed within the same departmental group. Practitioners can focus their efforts on the specific preferences of the 2 distinct examiners involved. Having 2 of the 3 pending actions with a single examiner, DANG, ANH TIEU, provides a significant opportunity to streamline responses and align arguments for the majority of the portfolio.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (33%) |
| §102 only | 1 (33%) |
| Double-patenting only | 1 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| DANG, ANH TIEU | 2 | 65.7% | +34.8% |
| RODJOM, KATHERINE MARIE | 1 | 65.3% | +34.2% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18427167 | Controlled Tissue Dissection Systems and Methods | DANG, ANH TIEU | 34d |
| 19288727 | Controlled Tissue Dissection Systems and Methods | DANG, ANH TIEU | — |
| 18726203 | MEDICAL DILATOR WITH ECHOGENETIC MARKER | RODJOM, KATHERINE MARIE | — |
| Art Unit | Apps |
|---|---|
| 3771 | 3 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19288727 | Controlled Tissue Dissection Systems and Methods | DANG, ANH TIEU | 3771 | §102 | Non-Final OA | — | Pending | Aug 01, 2025 |
| 18726203 | MEDICAL DILATOR WITH ECHOGENETIC MARKER | RODJOM, KATHERINE MARIE | 3771 | §103 | Non-Final OA | — | Pending | Jul 02, 2024 |
| 18427167 | Controlled Tissue Dissection Systems and Methods | DANG, ANH TIEU | 3771 | DP | Final Rejection | 34d | Pending | Jan 30, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialBioprotect Ltd. has 3 pending office actions as of October 2026, spread across 1 art units and 2 examiners.
Anh Tieu Dang has the most, with 2 of Bioprotect Ltd.'s pending office actions.
Mostly Medical Devices & Mechanical Engineering (USPTO Tech Center 3700), based on where its pending office actions are examined.
